Article (Scientific journals)
Benefit of revascularization for stable ischaemic heart disease: the jury is still out.
Fassa, Amir-Ali; Wijns, William; Kolh, Philippe et al.
2013In European Heart Journal, 34 (21), p. 1534-8
Peer Reviewed verified by ORBi
 

Files


Full Text
Fassa_Eur Heart J_2013_34_1534.pdf
Publisher postprint (178.33 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Coronary Artery Bypass; Fractional Flow Reserve, Myocardial/physiology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Myocardial Ischemia/physiopathology/therapy; Myocardial Revascularization; Patient Selection; Percutaneous Coronary Intervention; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Fassa, Amir-Ali
Wijns, William
Kolh, Philippe  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et path.
Steg, Philippe Gabriel
Language :
English
Title :
Benefit of revascularization for stable ischaemic heart disease: the jury is still out.
Publication date :
2013
Journal title :
European Heart Journal
ISSN :
0195-668X
eISSN :
1522-9645
Publisher :
Oxford University Press, United Kingdom
Volume :
34
Issue :
21
Pages :
1534-8
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 13 February 2014

Statistics


Number of views
34 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
8
Scopus citations®
without self-citations
5
OpenCitations
 
6

Bibliography


Similar publications



Contact ORBi